federal_register: 2021-26118
This data as json
| document_number | title | type | abstract | publication_date | pub_year | pub_month | html_url | pdf_url | agency_names | agency_ids | excerpts |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-26118 | Advisory Committee; Patient Engagement Advisory Committee; Renewal | Notice | The Food and Drug Administration (FDA) is announcing the renewal of the Patient Engagement Advisory Committee by the Commissioner of Food and Drugs (the Commissioner). The Commissioner has determined that it is in the public interest to renew the Patient Engagement Advisory Committee for an additional 2 years beyond the charter expiration date. The new charter will be in effect until the October 6, 2023, expiration date. | 2021-12-01 | 2021 | 12 | https://www.federalregister.gov/documents/2021/12/01/2021-26118/advisory-committee-patient-engagement-advisory-committee-renewal | https://www.govinfo.gov/content/pkg/FR-2021-12-01/pdf/2021-26118.pdf | Health and Human Services Department; Food and Drug Administration | 221,199 | The Food and Drug Administration (FDA) is announcing the renewal of the Patient Engagement Advisory Committee by the Commissioner of Food and Drugs (the Commissioner). The Commissioner has determined that it is in the public interest to renew the... |